IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Marinus Pharmaceuticals
Symbol: MRNS
Price: Last trade $7.73
Trade Date: 11/6
Shares: 3.9 million
Underwriter(s) Jefferies, RBC Capital Markets
Rating=Subscription Needed
Company: ServiceMaster Global Holdings-BLOCK
Symbol: SERV
Price: Last trade $34.60
Trade Date: 11/6
Shares: 29 million
Underwriter(s) J.P. Morgan
Rating=Subscription Needed
Secondaries announced 11.5.2015